Home and community exposures in COPD exacerbation: A pilot case cross-over study

COPD 恶化中的家庭和社区暴露:试点案例交叉研究

基本信息

  • 批准号:
    8135528
  • 负责人:
  • 金额:
    $ 17.55万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2010
  • 资助国家:
    美国
  • 起止时间:
    2010-09-01 至 2013-08-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by investigator): Preventing chronic obstructive pulmonary disease (COPD) exacerbation is the most important method for prolonging the productive life of COPD patients, and rapid response to respiratory infection is known to reduce the severity of exacerbations. At least 2 environmental exposures may also trigger exacerbations - tobacco smoke (both active and passive smoking) and urban air pollution. Beyond these, little is known about exposures to respiratory irritants and other pollutants in the home, community and work that might exacerbate COPD. Studies of asthma, bronchial hyper reactivity and acute loss of pulmonary function have reported common and substantial indoor exposures to respiratory toxins including irritants, with effects similar to if not stronger than those reported for urban air pollution. We hypothesize that reducing exposure to agents associated with asthma and other acute respiratory effects may also reduce exacerbation frequency in COPD patients. This pilot study will use a case-crossover design to identify triggering environmental exposures in the days immediately preceding an exacerbation by comparing these exposures to those in randomly chosen weeks when participants are not experiencing exacerbations. Because no validated survey instrument has been identified for this purpose, we will develop an interviewer-administered questionnaire to gather data for the previous week on exposures to respiratory irritants and particulates as well as on activities generating these exposures in the home, community and work. Questions will be drawn from published instruments assessing whether and how often the exposures of interest were encountered, or the exposure-generating activities occurred. The study population will be 200 COPD patients enrolled in the disease management group of a large health maintenance organization. The population will be followed for 1 year. We expect that on average we will gather data on 1 exacerbation and 3 referent periods for each of the 200 participants. COPD patients are instructed to phone a nurse whenever they notice the onset of an exacerbation. Telephone interviews will be conducted at these times, as well as at least 3 other random times during the year. Exacerbations will be clinically confirmed by a trained clinician using standard criteria which consider increased severity of signs and symptoms as well as changes in medication usage. The intervew will gather data on respiratory symptoms and exposures in the home, community and work, including both active and passive smoking. This pilot study will identify evidence supporting future research with quantitative exposure assessment of specific chemical agents. The proposed study would be the first to use the powerful case-crossover design to identify environmental triggers of COPD exacerbation, potentially leading to important new strategies for prevention of this severe and disabling disease. PUBLIC HEALTH RELEVANCE: We hypothesize that air pollutants associated with asthma and other acute respiratory effects in the home, community and workplace may trigger exacerbation of COPD. The proposed research will study members of a COPD disease management group, and use a case-crossover design to identify triggering environmental exposures in the days immediately preceding a clinically confirmed exacerbation by comparing these exposures to those in randomly chosen weeks when patients are not experiencing exacerbations. The proposed study would be the first to use the powerful case-crossover design to identify environmental triggers of COPD exacerbation, potentially leading to important new strategies for prevention of this severe and disabling disease.
描述(由研究者提供):预防慢性阻塞性肺疾病(COPD)急性加重是延长COPD患者生产生活的最重要方法,已知对呼吸道感染的快速反应可降低急性加重的严重程度。至少有两种环境暴露也可能引发病情加重-烟草烟雾(主动吸烟和被动吸烟)和城市空气污染。除此之外,人们对家庭、社区和工作中可能加剧COPD的呼吸道刺激物和其他污染物的暴露知之甚少。对哮喘、支气管高反应性和肺功能急性丧失的研究报告了常见的大量室内呼吸道毒素,包括刺激物,其影响与城市空气污染报告的影响相似,如果不是更强的话。我们假设,减少暴露于与哮喘和其他急性呼吸系统影响相关的药物也可能降低COPD患者的急性加重频率。 本初步研究将使用病例交叉设计,通过将急性加重前几天的触发环境暴露与受试者未发生急性加重时随机选择的周内的暴露进行比较,确定这些暴露。由于尚未确定用于此目的的有效调查工具,因此我们将开发一份由访谈者管理的问卷,以收集前一周呼吸道刺激物和颗粒物暴露以及家庭、社区和工作中产生这些暴露的活动的数据。将从已公布的工具中提出问题,评估是否遇到感兴趣的风险或产生风险的活动以及发生的频率。 研究人群将是入组大型健康维护组织疾病管理组的200例COPD患者。人群将随访1年。我们预计,平均而言,我们将为200名参与者中的每名参与者收集1次急性加重和3个参考期的数据。指导COPD患者在注意到病情加重时给护士打电话。电话采访将在这些时间进行,以及在一年中至少3个其他随机时间。将由经过培训的临床医生使用标准标准(考虑体征和症状的严重程度增加以及药物使用的变化)对急性加重进行临床确认。这次调查将收集有关呼吸道症状和在家庭、社区和工作场所暴露的数据,包括主动吸烟和被动吸烟。这项试点研究将确定支持未来研究的证据,对特定化学制剂进行定量暴露评估。这项拟议的研究将是第一个使用强大的病例交叉设计来识别COPD急性加重的环境触发因素,可能导致预防这种严重和致残性疾病的重要新策略。 公共卫生相关性:我们假设,在家庭、社区和工作场所与哮喘和其他急性呼吸系统影响相关的空气污染物可能会引发COPD恶化。拟议的研究将研究COPD疾病管理组的成员,并使用病例交叉设计,通过将这些暴露与随机选择的患者未发生急性加重的周内的暴露进行比较,来确定临床确认急性加重前几天的触发环境暴露。这项拟议的研究将是第一个使用强大的病例交叉设计来识别COPD急性加重的环境触发因素,可能导致预防这种严重和致残性疾病的重要新策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

SUSAN R SAMA其他文献

SUSAN R SAMA的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('SUSAN R SAMA', 18)}}的其他基金

Home and community exposures in COPD exacerbation: A pilot case cross-over study
COPD 恶化中的家庭和社区暴露:试点案例交叉研究
  • 批准号:
    7990715
  • 财政年份:
    2010
  • 资助金额:
    $ 17.55万
  • 项目类别:
Physiologic Characterization of Occupational Asthma
职业性哮喘的生理特征
  • 批准号:
    6661888
  • 财政年份:
    2002
  • 资助金额:
    $ 17.55万
  • 项目类别:
Physiologic Characterization of Occupational Asthma
职业性哮喘的生理特征
  • 批准号:
    6471660
  • 财政年份:
    2002
  • 资助金额:
    $ 17.55万
  • 项目类别:
Physiologic Characterization of Occupational Asthma
职业性哮喘的生理特征
  • 批准号:
    6757901
  • 财政年份:
    2002
  • 资助金额:
    $ 17.55万
  • 项目类别:
CHRONIC SINUSITIS AND OCCUPATIONAL RESPIRATORY DISEASE
慢性鼻窦炎和职业性呼吸系统疾病
  • 批准号:
    2657246
  • 财政年份:
    1996
  • 资助金额:
    $ 17.55万
  • 项目类别:
CHRONIC SINUSITIS AND OCCUPATIONAL RESPIRATORY DISEASE
慢性鼻窦炎和职业性呼吸系统疾病
  • 批准号:
    2657666
  • 财政年份:
    1996
  • 资助金额:
    $ 17.55万
  • 项目类别:

相似海外基金

Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
  • 批准号:
    MR/X02329X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.55万
  • 项目类别:
    Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
  • 批准号:
    MR/Y009568/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.55万
  • 项目类别:
    Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
  • 批准号:
    10090332
  • 财政年份:
    2024
  • 资助金额:
    $ 17.55万
  • 项目类别:
    Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
  • 批准号:
    MR/X021882/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.55万
  • 项目类别:
    Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
  • 批准号:
    2312694
  • 财政年份:
    2024
  • 资助金额:
    $ 17.55万
  • 项目类别:
    Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
  • 批准号:
    EP/Y003527/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.55万
  • 项目类别:
    Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
  • 批准号:
    EP/Y030338/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.55万
  • 项目类别:
    Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
  • 批准号:
    MR/X029557/1
  • 财政年份:
    2024
  • 资助金额:
    $ 17.55万
  • 项目类别:
    Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
  • 批准号:
    24K19395
  • 财政年份:
    2024
  • 资助金额:
    $ 17.55万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
  • 批准号:
    2244994
  • 财政年份:
    2023
  • 资助金额:
    $ 17.55万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了